International Journal of Molecular Medical Science, 2025, Vol.15, No.1, 9-19 http://medscipublisher.com/index.php/ijmms 18 Berger M., and Mardis E., 2018, The emerging clinical relevance of genomics in cancer medicine, Nature Reviews Clinical Oncology, 15: 353-365. https://doi.org/10.1038/s41571-018-0002-6 Campos-Carrillo A., Weitzel J., Sahoo P., Rockne R., Mokhnatkin J., Murtaza M., Gray S., Goetz L., Goel A., Schork N., and Slavin T., 2019, Circulating tumor DNA as an early cancer detection tool, Pharmacology and Therapeutics, 207: 107458. https://doi.org/10.1016/j.pharmthera.2019.107458 Cescon D., Bratman S., Chan S., and Siu L., 2020, Circulating tumor DNA and liquid biopsy in oncology, Nature Cancer, 1: 276-290. https://doi.org/10.1038/s43018-020-0043-5 Chang Y.A., Weng S.L., Yang S.F., Chou C.H., Huang W.C., Tu S.J., Chang T.H., Huang C.N., Jong Y.J., and Huang H.D., 2018, A three-microRNA signature as a potential biomarker for the early detection of oral cancer, International Journal of Molecular Science, 19(3): 758. https://doi.org/10.3390/ijms19030758 Chen M., and Zhao H., 2019, Next-generation sequencing in liquid biopsy: cancer screening and early detection, Human Genomics, 13(1): 34. https://doi.org/10.1186/s40246-019-0220-8 D'Souza W.Y., and Saranath D., 2017, OMICS, oral cancer molecular landscapes, and clinical practice, Omics, 21(12): 689-703. https://doi.org/10.1089/omi.2017.0146 Fang W., Chen Y., Hsiao J., Liu C., Kuo Y., Wang Y., Chang K., Tsai S., Chang M., Lin S., and Wu L., 2015, Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production, Oncotarget, 6(29): 28401-28424. https://doi.org/10.18632/oncotarget.4951 Falzone L., Lupo G., Rosa G., Crimi S., Anfuso C., Salemi R., Rapisarda E., Libra M., and Candido S., 2019, Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer, Cancers, 11(5): 610. https://doi.org/10.3390/cancers11050610 He Q., Chen Z., Cabay R., Zhang L., Luan X., Chen D., Yu T., Wang A., and Zhou X., 2016, MicroRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection, Oral Oncology, 57: 15-20. https://doi.org/10.1016/j.oraloncology.2016.03.017 Jafari M., and Hasanzadeh M., 2020, Non-invasive bioassay of Cytokeratin Fragment 21.1 (Cyfra 21.1) protein in human saliva samples using immunoreaction method: an efficient platform for early-stage diagnosis of oral cancer based on biomedicine, Biomedicine and Pharmacotherapy, 131; 110671. https://doi.org/10.1016/j.biopha.2020.110671 Khurshid Z., Zafar M., Khan R., Najeeb S., Slowey P., and Rehman I., 2018, Role of salivary biomarkers in oral cancer detection, Advances in Clinical Chemistry, 86: 23-70. https://doi.org/10.1016/bs.acc.2018.05.002 Liyanage C., Wathupola A., Muraleetharan S., Perera K., Punyadeera C., and Udagama P., 2019, Promoter hypermethylation of tumor-suppressor genes p16INK4a, RASSF1A, TIMP3, and PCQAP/MED15 in salivary DNA as a quadruple biomarker panel for early detection of oral and oropharyngeal cancers, Biomolecules, 9(4): 148. https://doi.org/10.3390/biom9040148 Lin C., Liu X., Zheng B., Ke R.Q., and Tzeng C., 2021, Liquid biopsy, ctDNA diagnosis through NGS, Life, 11(9): 890. https://doi.org/10.3390/life11090890 Leighl N., Page R., Raymond V., Daniel D., Divers S., Reckamp K., Villalona-Calero M., Dix D., Odegaard J., Lanman R., and Papadimitrakopoulou V., 2019, Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non–small cell lung cancer, Clinical Cancer Research, 25: 4691-4700. https://doi.org/10.1158/1078-0432.CCR-19-0624 Li Y., Cao X., and Li H., 2020, Identification and validation of novel long non-coding RNA biomarkers for early diagnosis of oral squamous cell carcinoma, Frontiers in Bioengineering and Biotechnology, 8: 256. https://doi.org/10.3389/fbioe.2020.00256 Kim S., Lee J., and Park Y., 2020, The application of next-generation sequencing to define factors related to oral cancer and discover novel biomarkers, Life, 10(10): 228. https://doi.org/10.3390/life10100228 Nakamura Y., Taniguchi H., Ikeda M., Bando H., Kato K., Morizane C., Esaki T., Komatsu Y., Kawamoto Y., Takahashi N., Ueno M., Kagawa Y., Nishina T., Kato T., Yamamoto Y., Furuse J., Denda T., Kawakami H., Oki E., Nakajima T., Nishida N., Yamaguchi K., Yasui H., Goto M., Matsuhashi N., Ohtsubo K., Yamazaki K., Tsuji A., Okamoto W., Tsuchihara K., Yamanaka T., Miki I., Sakamoto Y., Ichiki H., Hata M., Yamashita R., Ohtsu A., Odegaard J., and Yoshino T., 2020, Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies, Nature Medicine, 26(12): 1859-1864. https://doi.org/10.1038/s41591-020-1063-5 Nakamura Y., and Shitara K., 2020, Development of circulating tumour DNA analysis for gastrointestinal cancers, ESMO Open, 5(Suppl 1): e000600. https://doi.org/10.1136/esmoopen-2019-000600 Nakamura Y., and Yoshino T., 2018, Clinical utility of analyzing circulating tumor DNA in patients with metastatic colorectal cancer, The Oncologist, 23(11): 1310-1318. https://doi.org/10.1634/theoncologist.2017-0621
RkJQdWJsaXNoZXIy MjQ4ODYzNA==